Expanded Genetic Screening Act

Bill: 118-hr-5864
Sponsor: full_name: Rep. Fitzpatrick, Brian K. [R-PA-1]
Introduced: 2023-10-02
Policy area: Health
Subjects: Child health

Genetics

Health care coverage and access

Health information and medical records

Medicaid

Medical tests and diagnostic methods

Sex and reproductive health

Women's health
Latest action: action_date: 2023-10-06
text: Referred to the Subcommittee on Health.

Summaries:
action_date: 2023-10-02
action_desc: Introduced in House
text: <p><b>Expanded Genetic Screening Act</b></p> <p>This bill requires state Medicaid programs to cover noninvasive prenatal genetic screening for pregnant women, subject to certain informed consent requirements. (Noninvasive prenatal genetic screening uses naturally occurring fetal DNA from the mother's blood to screen for genetic abnormalities.)</p>

tv_txt: I 118th CONGRESS 1st Session H. R. 5864 IN THE HOUSE OF REPRESENTATIVES October 2, 2023 Mr. Fitzpatrick (for himself and Ms. Clarke of New York ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To amend title XIX of the Social Security Act to provide for coverage under the Medicaid program of non-invasive prenatal genetic screening.

1. Short title This Act may be cited as the Expanded Genetic Screening Act . 2. Medicaid coverage of non-invasive prenatal genetic screening (a) In general Section 1905 of the Social Security Act ( 42 U.S.C. 1396d ) is amended— (1) in subsection (a)(3)— (A) in subparagraph (A), by striking at the end and ; (B) in subparagraph (B), by inserting and after the semicolon; and (C) by adding at the end the following new subparagraph: (C) non-invasive prenatal genetic screening for pregnant women of all age groups (provided in a facility, a home, or other setting), subject to the informed consent requirement described in subsection (jj); ; and (2) by adding at the end the following new subsection: (jj) Informed consent requirement for non-invasive prenatal genetic screening (1) In general For purposes of subsection (a)(3)(C), the informed consent requirement described in this subsection for non-invasive prenatal genetic screening furnished to a pregnant woman is that, prior to furnishing the screening to the woman, the provider of the screening gives the woman a full disclosure that includes, at a minimum, the following information: (A) The limitations of the screening platform for any genetic screen or test with the goal to identify risk or diagnose a genetic condition. (B) Any potential interferences that may affect the screening's performance. (C) Information about predictive values used by the screening based on appropriate matching population and inherent risk factors based on age, family history, and other aneuploidy risk factors (such as ultrasound abnormalities). (D) The need for follow-up diagnostic testing to confirm true positive results before decisions are made about irrevocable clinical intervention. (2) No medical assistance available for screenings provided without consent No payment may be made under section 1903(a) with respect to a non-invasive prenatal genetic screening that is furnished to a pregnant woman without meeting the requirement described in paragraph (1). . (b) Conforming amendment Section 1903(i) of the Social Security Act ( 42 U.S.C. 1396b(i) ) is amended— (1) in paragraph (26), by striking ; or ; (2) in paragraph (27), by striking the period and inserting ; or ; and (3) by inserting after paragraph (27) the following new paragraph: (28) with respect to amounts expended for non-invasive prenatal genetic screening services furnished to a pregnant woman, unless the informed consent requirement of section 1905(jj) is met. .